Profile
Full Name
Palvella Therapeutics, Inc.Ticker Symbol
PVLAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
January 2, 2015Indexes
Not includedWebsite
http://palvellatx.comEmployees
14Key Details
Price
$21.76(+9.51%)
Market cap
$239.77M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$7.83(-590.45% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Palvella Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 Chardan Capital
BuyApr 1, 25 HC Wainwright & Co.
BuyMar 26, 25 Stifel
BuyMar 25, 25 Jones Trading
BuyMar 7, 25 Scotiabank
Sector OutperformFeb 26, 25 Canaccord Genuity
BuyFeb 20, 25 Canaccord Genuity
BuyFeb 11, 25 HC Wainwright & Co.
BuyFeb 5, 25 TD Cowen
BuyJan 10, 25 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Palvella Therapeutics?
- Does Palvella Therapeutics pay dividends?
- What sector is Palvella Therapeutics in?
- What industry is Palvella Therapeutics in?
- What country is Palvella Therapeutics based in?
- When did Palvella Therapeutics go public?
- Is Palvella Therapeutics in the S&P 500?
- Is Palvella Therapeutics in the NASDAQ 100?
- Is Palvella Therapeutics in the Dow Jones?
- When was Palvella Therapeutics's last earnings report?
- When does Palvella Therapeutics report earnings?
- Should I buy Palvella Therapeutics stock now?
What is the ticker symbol for Palvella Therapeutics?
The ticker symbol for Palvella Therapeutics is NASDAQ:PVLA
Does Palvella Therapeutics pay dividends?
No, Palvella Therapeutics does not pay dividends
What sector is Palvella Therapeutics in?
Palvella Therapeutics is in the Healthcare sector
What industry is Palvella Therapeutics in?
Palvella Therapeutics is in the Biotechnology industry
What country is Palvella Therapeutics based in?
Palvella Therapeutics is headquartered in United States
When did Palvella Therapeutics go public?
Palvella Therapeutics's initial public offering (IPO) was on January 2, 2015
Is Palvella Therapeutics in the S&P 500?
No, Palvella Therapeutics is not included in the S&P 500 index
Is Palvella Therapeutics in the NASDAQ 100?
No, Palvella Therapeutics is not included in the NASDAQ 100 index
Is Palvella Therapeutics in the Dow Jones?
No, Palvella Therapeutics is not included in the Dow Jones index
When was Palvella Therapeutics's last earnings report?
Palvella Therapeutics's most recent earnings report was on Mar 31, 2025
When does Palvella Therapeutics report earnings?
The next expected earnings date for Palvella Therapeutics is May 30, 2025
Should I buy Palvella Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions